Global vertebroplasty, kyphoplasty market gains steam with boost in osteoporosis: 8 observations

Written by Megan Wood | July 21, 2017 | Print  | Email

The global vertebroplasty and kyphoplasty market will expand, according to a Transparency Market Research report.

Here are eight observations:

 

1. Complications with the traditional approach for treating vertebral compression fractures will drive the global vertebroplasty and kyphoplasty market.

 

2. The increasing geriatric population is boosting the prevalence of osteoporosis cases, which may lead to VCFs.

 

3. Vertebroplasty and kyphoplasty are intended to stabilize and relieve VCF-related pain.

 

4. The risk of another fracture and postoperative complications may hinder market growth, however.

 

5. The North American market saw the highest revenue generated from vertebroplasty and kyphoplasty devices. This is due to established healthcare infrastructure and patient compliance with the devices.

 

6. The European market is also strong, owing to healthcare technological advancements.

 

7. The Asia-Pacific market will grow at the highest compound annual growth rate due to opportunities in India and China.

 

8. Leading players in the market include DePuy Synthes, CareFusion Corp., Alphatec Spine, G-21 s.r.l., Medtronic, Stryker, Osseon, Taeyeon Medical Co., BMK Global Medical Company, Globus Medical and SOMATEX.

 

More articles on devices:
Spinal cord stimulation market to grow at a 9.2% CAGR through 2021 — 5 observations
4 key notes on Stryker mid-year
Dr. Steven DeLuca performs 1st surgery in Premia Spine's FDA pivotal study: 5 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.